U.S. markets open in 1 hour 28 minutes
  • S&P Futures

    3,811.25
    -27.75 (-0.72%)
     
  • Dow Futures

    31,403.00
    -62.00 (-0.20%)
     
  • Nasdaq Futures

    12,463.00
    -200.75 (-1.59%)
     
  • Russell 2000 Futures

    2,180.80
    -8.90 (-0.41%)
     
  • Crude Oil

    65.91
    -0.18 (-0.27%)
     
  • Gold

    1,688.00
    -10.50 (-0.62%)
     
  • Silver

    25.23
    -0.06 (-0.25%)
     
  • EUR/USD

    1.1864
    -0.0061 (-0.51%)
     
  • 10-Yr Bond

    1.5540
    0.0000 (0.00%)
     
  • Vix

    27.54
    -1.03 (-3.61%)
     
  • GBP/USD

    1.3828
    +0.0000 (+0.00%)
     
  • USD/JPY

    108.6900
    +0.3080 (+0.28%)
     
  • BTC-USD

    50,271.11
    -417.45 (-0.82%)
     
  • CMC Crypto 200

    1,016.00
    +72.82 (+7.72%)
     
  • FTSE 100

    6,631.33
    +0.81 (+0.01%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Medtronic: Q3 Earnings Insights

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

 

Shares of Medtronic (NYSE:MDT) fell 0.2% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share decreased 10.42% over the past year to $1.29, which beat the estimate of $1.15.

Revenue of $7,775,000,000 higher by 0.75% from the same period last year, which missed the estimate of $7,780,000,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Feb 23, 2021

View more earnings on MDT

Time: 08:00 AM

ET Webcast URL: https://vimeo.com/event/700301

Price Action

Company's 52-week high was at $120.53

Company's 52-week low was at $72.13

Price action over last quarter: Up 1.49%

Company Description

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.